Gremlin1 is required for skeletal development and postnatal skeletal homeostasis
- 16 March 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 227 (1) , 269-277
Abstract
Gremlin is an antagonist of bone morphogenetic proteins, and its overexpression causes suppressed osteoblastogenesis and osteopenia. Inactivation of Grem1 results in severe developmental defects, but the consequences of the global inactivation of Grem1 on the postnatal skeleton are not known. To study the function of gremlin, Grem1 was inactivated by homologous recombination, and mice were maintained in a C57BL/6/FVB mixed genetic background due to embryonic and neonatal lethality in the uniform C57BL/6 background. Grem1 null mice exhibited developmental skeletal abnormalities, leading to incomplete formation of metatarsal bones and of fore limbs and hind limbs. Grem1 null mice exhibited decreased weight and body fat and shortened femoral length. Bone histomorphometric and microarchitectural analyses of distal femurs revealed decreased bone volume and increased bone formation in 1‐month‐old Grem1 null mice. Trabecular femoral bone volume was restored in older Grem1 null female mice, and to a lesser extent in male mice. Vertebral microarchitecture confirmed the osteopenia observed in 1‐month‐old Grem1 null mice and demonstrated recovery of trabecular bone in older female, but not in older male Grem1 null mice, which exhibited persistent vertebral osteopenia. In conclusion, Grem1 is not only necessary for skeletal development, but also for postnatal skeletal homeostasis; its inactivation causes osteopenia, which is partially reversed in a spatial, temporal, and sex‐dependent manner due to an increase in bone formation. J. Cell. Physiol. 227: 269–277, 2012.Keywords
This publication has 45 references indexed in Scilit:
- Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in VivoJournal of Biological Chemistry, 2010
- Connective Tissue Growth Factor Is Required for Skeletal Development and Postnatal Skeletal Homeostasis in Male MiceEndocrinology, 2010
- Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblastsJournal of Bone and Mineral Research, 2010
- Enhanced Osteoclastogenesis Causes Osteopenia in Twisted Gastrulation-Deficient Mice Through Increased BMP SignalingJournal of Bone and Mineral Research, 2009
- Phosphatidylinositol 3 Kinase/Akt Signal Relay Cooperates with Smad in Bone Morphogenetic Protein-2-Induced Colony Stimulating Factor-1 (CSF-1) Expression and Osteoclast DifferentiationEndocrinology, 2009
- BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathwayDevelopment, 2008
- Skeletal Overexpression of Connective Tissue Growth Factor Impairs Bone Formation and Causes OsteopeniaEndocrinology, 2008
- Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferationProceedings of the National Academy of Sciences, 2006
- Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterningNature Genetics, 2003
- Expression of the BMP 2 Gene during Bone Cell DifferentiationCritical Reviews™ in Eukaryotic Gene Expression, 1994